HNRPR_HUMAN - dbPTM
HNRPR_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HNRPR_HUMAN
UniProt AC O43390
Protein Name Heterogeneous nuclear ribonucleoprotein R
Gene Name HNRNPR
Organism Homo sapiens (Human).
Sequence Length 633
Subcellular Localization Nucleus . Microsome . Nucleus, nucleoplasm . Cytoplasm . Localized in cytoplasmic mRNP granules containing untranslated mRNAs. The tyrosine phosphorylated form bound to RNA is found in microsomes (By similarity).
Protein Description Component of ribonucleosomes, which are complexes of at least 20 other different heterogenious nuclear ribonucleoproteins (hnRNP). hnRNP play an important role in processing of precursor mRNA in the nucleus..
Protein Sequence MANQVNGNAVQLKEEEEPMDTSSVTHTEHYKTLIEAGLPQKVAERLDEIFQTGLVAYVDLDERAIDALREFNEEGALSVLQQFKESDLSHVQNKSAFLCGVMKTYRQREKQGSKVQESTKGPDEAKIKALLERTGYTLDVTTGQRKYGGPPPDSVYSGVQPGIGTEVFVGKIPRDLYEDELVPLFEKAGPIWDLRLMMDPLSGQNRGYAFITFCGKEAAQEAVKLCDSYEIRPGKHLGVCISVANNRLFVGSIPKNKTKENILEEFSKVTEGLVDVILYHQPDDKKKNRGFCFLEYEDHKSAAQARRRLMSGKVKVWGNVVTVEWADPVEEPDPEVMAKVKVLFVRNLATTVTEEILEKSFSEFGKLERVKKLKDYAFVHFEDRGAAVKAMDEMNGKEIEGEEIEIVLAKPPDKKRKERQAARQASRSTAYEDYYYHPPPRMPPPIRGRGRGGGRGGYGYPPDYYGYEDYYDDYYGYDYHDYRGGYEDPYYGYDDGYAVRGRGGGRGGRGAPPPPRGRGAPPPRGRAGYSQRGAPLGPPRGSRGGRGGPAQQQRGRGSRGSRGNRGGNVGGKRKADGYNQPDSKRRQTNNQQNWGSQPIAQQPLQQGGDYSGNYGYNNDNQEFYQDTYGQQWK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MANQVNGNA
------CCCCCCCCC
18.3722223895
13SumoylationNGNAVQLKEEEEPMD
CCCCEECCCCCCCCC
46.09-
13SumoylationNGNAVQLKEEEEPMD
CCCCEECCCCCCCCC
46.0928112733
21PhosphorylationEEEEPMDTSSVTHTE
CCCCCCCCCCCCHHH
19.3623401153
22PhosphorylationEEEPMDTSSVTHTEH
CCCCCCCCCCCHHHH
20.6730266825
22 (in isoform 2)Phosphorylation-20.6727251275
23PhosphorylationEEPMDTSSVTHTEHY
CCCCCCCCCCHHHHH
32.8830266825
25PhosphorylationPMDTSSVTHTEHYKT
CCCCCCCCHHHHHHH
25.6530266825
27PhosphorylationDTSSVTHTEHYKTLI
CCCCCCHHHHHHHHH
18.3230266825
30PhosphorylationSVTHTEHYKTLIEAG
CCCHHHHHHHHHHCC
10.2320873877
31UbiquitinationVTHTEHYKTLIEAGL
CCHHHHHHHHHHCCC
38.47-
32PhosphorylationTHTEHYKTLIEAGLP
CHHHHHHHHHHCCCC
26.2925159151
41AcetylationIEAGLPQKVAERLDE
HHCCCCHHHHHHHHH
41.2827452117
41UbiquitinationIEAGLPQKVAERLDE
HHCCCCHHHHHHHHH
41.2821890473
41 (in isoform 1)Ubiquitination-41.2821890473
41 (in isoform 2)Ubiquitination-41.2821890473
41UbiquitinationIEAGLPQKVAERLDE
HHCCCCHHHHHHHHH
41.2821890473
52PhosphorylationRLDEIFQTGLVAYVD
HHHHHHHHCCEEEEE
23.0228450419
57PhosphorylationFQTGLVAYVDLDERA
HHHCCEEEEECCHHH
6.2428450419
69MethylationERAIDALREFNEEGA
HHHHHHHHHHCHHHH
48.45115479377
78PhosphorylationFNEEGALSVLQQFKE
HCHHHHHHHHHHHHH
21.9021712546
842-HydroxyisobutyrylationLSVLQQFKESDLSHV
HHHHHHHHHHCCHHH
52.55-
84AcetylationLSVLQQFKESDLSHV
HHHHHHHHHHCCHHH
52.5525825284
84UbiquitinationLSVLQQFKESDLSHV
HHHHHHHHHHCCHHH
52.55-
942-HydroxyisobutyrylationDLSHVQNKSAFLCGV
CCHHHCCHHHHHHHH
26.52-
94AcetylationDLSHVQNKSAFLCGV
CCHHHCCHHHHHHHH
26.5226051181
94UbiquitinationDLSHVQNKSAFLCGV
CCHHHCCHHHHHHHH
26.52-
95PhosphorylationLSHVQNKSAFLCGVM
CHHHCCHHHHHHHHH
31.6321712546
99GlutathionylationQNKSAFLCGVMKTYR
CCHHHHHHHHHHHHH
2.8922555962
1032-HydroxyisobutyrylationAFLCGVMKTYRQREK
HHHHHHHHHHHHHHH
39.74-
103AcetylationAFLCGVMKTYRQREK
HHHHHHHHHHHHHHH
39.7423954790
103MalonylationAFLCGVMKTYRQREK
HHHHHHHHHHHHHHH
39.7426320211
103UbiquitinationAFLCGVMKTYRQREK
HHHHHHHHHHHHHHH
39.74-
113PhosphorylationRQREKQGSKVQESTK
HHHHHHCCCCHHHCC
27.4530108239
114AcetylationQREKQGSKVQESTKG
HHHHHCCCCHHHCCC
55.5526051181
114UbiquitinationQREKQGSKVQESTKG
HHHHHCCCCHHHCCC
55.55-
118PhosphorylationQGSKVQESTKGPDEA
HCCCCHHHCCCCCHH
20.5130108239
119PhosphorylationGSKVQESTKGPDEAK
CCCCHHHCCCCCHHH
38.9930108239
126TrimethylationTKGPDEAKIKALLER
CCCCCHHHHHHHHHH
42.57-
1262-HydroxyisobutyrylationTKGPDEAKIKALLER
CCCCCHHHHHHHHHH
42.57-
126AcetylationTKGPDEAKIKALLER
CCCCCHHHHHHHHHH
42.5723749302
126MethylationTKGPDEAKIKALLER
CCCCCHHHHHHHHHH
42.57-
126UbiquitinationTKGPDEAKIKALLER
CCCCCHHHHHHHHHH
42.57-
128TrimethylationGPDEAKIKALLERTG
CCCHHHHHHHHHHHC
32.07-
128MethylationGPDEAKIKALLERTG
CCCHHHHHHHHHHHC
32.07-
134PhosphorylationIKALLERTGYTLDVT
HHHHHHHHCCEEEEC
25.7621406692
136PhosphorylationALLERTGYTLDVTTG
HHHHHHCCEEEECCC
11.9721406692
137PhosphorylationLLERTGYTLDVTTGQ
HHHHHCCEEEECCCC
20.1621406692
141PhosphorylationTGYTLDVTTGQRKYG
HCCEEEECCCCCCCC
25.5221406692
142PhosphorylationGYTLDVTTGQRKYGG
CCEEEECCCCCCCCC
31.0321406692
146AcetylationDVTTGQRKYGGPPPD
EECCCCCCCCCCCCC
40.1226051181
146UbiquitinationDVTTGQRKYGGPPPD
EECCCCCCCCCCCCC
40.12-
147PhosphorylationVTTGQRKYGGPPPDS
ECCCCCCCCCCCCCC
29.5128152594
156PhosphorylationGPPPDSVYSGVQPGI
CCCCCCHHCCCCCCC
12.03-
171AcetylationGTEVFVGKIPRDLYE
CCEEEEECCCCHHHC
44.2125953088
171SumoylationGTEVFVGKIPRDLYE
CCEEEEECCCCHHHC
44.2128112733
171UbiquitinationGTEVFVGKIPRDLYE
CCEEEEECCCCHHHC
44.21-
171 (in isoform 2)Ubiquitination-44.21-
177PhosphorylationGKIPRDLYEDELVPL
ECCCCHHHCCCCHHH
26.1421712546
187UbiquitinationELVPLFEKAGPIWDL
CCHHHHHHHCCCEEE
51.8421906983
187 (in isoform 2)Ubiquitination-51.84-
195MethylationAGPIWDLRLMMDPLS
HCCCEEEEEEECCCC
20.33-
197SulfoxidationPIWDLRLMMDPLSGQ
CCEEEEEEECCCCCC
2.0128465586
198SulfoxidationIWDLRLMMDPLSGQN
CEEEEEEECCCCCCC
5.9328465586
208PhosphorylationLSGQNRGYAFITFCG
CCCCCCCEEEEEECC
8.6320090780
212PhosphorylationNRGYAFITFCGKEAA
CCCEEEEEECCHHHH
13.3529083192
214S-palmitoylationGYAFITFCGKEAAQE
CEEEEEECCHHHHHH
5.9529575903
216AcetylationAFITFCGKEAAQEAV
EEEEECCHHHHHHHH
45.4126051181
217UbiquitinationFITFCGKEAAQEAVK
EEEECCHHHHHHHHH
34.2221890473
2242-HydroxyisobutyrylationEAAQEAVKLCDSYEI
HHHHHHHHHHHCCCC
50.90-
224AcetylationEAAQEAVKLCDSYEI
HHHHHHHHHHHCCCC
50.9025953088
224UbiquitinationEAAQEAVKLCDSYEI
HHHHHHHHHHHCCCC
50.90-
226GlutathionylationAQEAVKLCDSYEIRP
HHHHHHHHHCCCCCC
2.4322555962
228PhosphorylationEAVKLCDSYEIRPGK
HHHHHHHCCCCCCCC
24.5428152594
229PhosphorylationAVKLCDSYEIRPGKH
HHHHHHCCCCCCCCC
11.3420090780
235AcetylationSYEIRPGKHLGVCIS
CCCCCCCCCEEEEEE
38.0425953088
235MethylationSYEIRPGKHLGVCIS
CCCCCCCCCEEEEEE
38.0423644510
252PhosphorylationNNRLFVGSIPKNKTK
CCEEEECCCCCCCCH
30.3430266825
252 (in isoform 2)Phosphorylation-30.3424719451
255UbiquitinationLFVGSIPKNKTKENI
EEECCCCCCCCHHHH
70.2121890473
255 (in isoform 1)Ubiquitination-70.2121890473
255 (in isoform 2)Ubiquitination-70.2121890473
257UbiquitinationVGSIPKNKTKENILE
ECCCCCCCCHHHHHH
68.08-
258O-linked_GlycosylationGSIPKNKTKENILEE
CCCCCCCCHHHHHHH
53.6532119511
2592-HydroxyisobutyrylationSIPKNKTKENILEEF
CCCCCCCHHHHHHHH
50.83-
259AcetylationSIPKNKTKENILEEF
CCCCCCCHHHHHHHH
50.8326051181
259MethylationSIPKNKTKENILEEF
CCCCCCCHHHHHHHH
50.83-
259UbiquitinationSIPKNKTKENILEEF
CCCCCCCHHHHHHHH
50.83-
279PhosphorylationGLVDVILYHQPDDKK
HHHHEEEEECCCCCC
6.31-
2852-HydroxyisobutyrylationLYHQPDDKKKNRGFC
EEECCCCCCCCCCEE
73.38-
285AcetylationLYHQPDDKKKNRGFC
EEECCCCCCCCCCEE
73.3825953088
286AcetylationYHQPDDKKKNRGFCF
EECCCCCCCCCCEEE
63.3725953088
289MethylationPDDKKKNRGFCFLEY
CCCCCCCCCEEEEEE
48.74-
292S-nitrosocysteineKKKNRGFCFLEYEDH
CCCCCCEEEEEECCH
4.19-
292GlutathionylationKKKNRGFCFLEYEDH
CCCCCCEEEEEECCH
4.1922555962
292S-nitrosylationKKKNRGFCFLEYEDH
CCCCCCEEEEEECCH
4.1922178444
292S-palmitoylationKKKNRGFCFLEYEDH
CCCCCCEEEEEECCH
4.1929575903
296PhosphorylationRGFCFLEYEDHKSAA
CCEEEEEECCHHHHH
28.8928152594
3002-HydroxyisobutyrylationFLEYEDHKSAAQARR
EEEECCHHHHHHHHH
54.86-
300AcetylationFLEYEDHKSAAQARR
EEEECCHHHHHHHHH
54.8623749302
300MalonylationFLEYEDHKSAAQARR
EEEECCHHHHHHHHH
54.8626320211
300UbiquitinationFLEYEDHKSAAQARR
EEEECCHHHHHHHHH
54.86-
303UbiquitinationYEDHKSAAQARRRLM
ECCHHHHHHHHHHHH
15.6221890473
311PhosphorylationQARRRLMSGKVKVWG
HHHHHHHHCCCEEEC
39.8024719451
3132-HydroxyisobutyrylationRRRLMSGKVKVWGNV
HHHHHHCCCEEECCE
31.41-
313UbiquitinationRRRLMSGKVKVWGNV
HHHHHHCCCEEECCE
31.41-
314 (in isoform 2)Phosphorylation-7.4424719451
328UbiquitinationVTVEWADPVEEPDPE
EEEEECCCCCCCCHH
27.8921890473
3412-HydroxyisobutyrylationPEVMAKVKVLFVRNL
HHHHHHEEEEEECCC
32.30-
341AcetylationPEVMAKVKVLFVRNL
HHHHHHEEEEEECCC
32.3025825284
341UbiquitinationPEVMAKVKVLFVRNL
HHHHHHEEEEEECCC
32.3021890473
341 (in isoform 1)Ubiquitination-32.3021890473
344 (in isoform 2)Ubiquitination-5.6321890473
350PhosphorylationLFVRNLATTVTEEIL
EEECCCCHHCCHHHH
25.6021712546
351PhosphorylationFVRNLATTVTEEILE
EECCCCHHCCHHHHH
21.5921712546
359SumoylationVTEEILEKSFSEFGK
CCHHHHHHHHHHCCC
54.0428112733
359UbiquitinationVTEEILEKSFSEFGK
CCHHHHHHHHHHCCC
54.0421906983
360PhosphorylationTEEILEKSFSEFGKL
CHHHHHHHHHHCCCH
25.3221815630
362PhosphorylationEILEKSFSEFGKLER
HHHHHHHHHCCCHHH
38.8222199227
362 (in isoform 2)Ubiquitination-38.82-
363 (in isoform 2)Phosphorylation-57.3127251275
366SumoylationKSFSEFGKLERVKKL
HHHHHCCCHHHHHHH
53.12-
366AcetylationKSFSEFGKLERVKKL
HHHHHCCCHHHHHHH
53.1219608861
366MethylationKSFSEFGKLERVKKL
HHHHHCCCHHHHHHH
53.1268337
366SumoylationKSFSEFGKLERVKKL
HHHHHCCCHHHHHHH
53.12-
366UbiquitinationKSFSEFGKLERVKKL
HHHHHCCCHHHHHHH
53.1221890473
366 (in isoform 1)Ubiquitination-53.1221890473
369AcetylationSEFGKLERVKKLKDY
HHCCCHHHHHHHCCE
56.8619608861
369UbiquitinationSEFGKLERVKKLKDY
HHCCCHHHHHHHCCE
56.8619608861
369 (in isoform 2)Ubiquitination-56.8621890473
3742-HydroxyisobutyrylationLERVKKLKDYAFVHF
HHHHHHHCCEEEEEE
58.53-
374AcetylationLERVKKLKDYAFVHF
HHHHHHHCCEEEEEE
58.5326051181
374UbiquitinationLERVKKLKDYAFVHF
HHHHHHHCCEEEEEE
58.53-
376PhosphorylationRVKKLKDYAFVHFED
HHHHHCCEEEEEECC
10.6028152594
379 (in isoform 2)Phosphorylation-3.7327642862
384MethylationAFVHFEDRGAAVKAM
EEEEECCCCHHHHHH
29.47115479383
3892-HydroxyisobutyrylationEDRGAAVKAMDEMNG
CCCCHHHHHHHHHCC
33.01-
389AcetylationEDRGAAVKAMDEMNG
CCCCHHHHHHHHHCC
33.0119608861
389UbiquitinationEDRGAAVKAMDEMNG
CCCCHHHHHHHHHCC
33.012190698
392AcetylationGAAVKAMDEMNGKEI
CHHHHHHHHHCCEEE
57.7819608861
392UbiquitinationGAAVKAMDEMNGKEI
CHHHHHHHHHCCEEE
57.7819608861
397AcetylationAMDEMNGKEIEGEEI
HHHHHCCEEECCEEE
50.9819608861
400AcetylationEMNGKEIEGEEIEIV
HHCCEEECCEEEEEE
62.7419608861
410UbiquitinationEIEIVLAKPPDKKRK
EEEEEEECCCCHHHH
53.58-
4142-HydroxyisobutyrylationVLAKPPDKKRKERQA
EEECCCCHHHHHHHH
61.32-
426PhosphorylationRQAARQASRSTAYED
HHHHHHHHHHHHHHH
20.5828450419
428PhosphorylationAARQASRSTAYEDYY
HHHHHHHHHHHHHCC
18.2021945579
429PhosphorylationARQASRSTAYEDYYY
HHHHHHHHHHHHCCC
31.9521945579
431PhosphorylationQASRSTAYEDYYYHP
HHHHHHHHHHCCCCC
14.9321945579
431 (in isoform 2)Phosphorylation-14.9324719451
434PhosphorylationRSTAYEDYYYHPPPR
HHHHHHHCCCCCCCC
8.2521945579
434 (in isoform 2)Phosphorylation-8.2527642862
435PhosphorylationSTAYEDYYYHPPPRM
HHHHHHCCCCCCCCC
13.9721945579
436PhosphorylationTAYEDYYYHPPPRMP
HHHHHCCCCCCCCCC
11.1321945579
437 (in isoform 2)Phosphorylation-16.5727642862
438 (in isoform 2)Phosphorylation-25.1927642862
439 (in isoform 2)Phosphorylation-18.8027642862
441MethylationYYYHPPPRMPPPIRG
CCCCCCCCCCCCCCC
56.8958857897
483MethylationGYDYHDYRGGYEDPY
CCCCCCCCCCCCCCC
37.81-
491PhosphorylationGGYEDPYYGYDDGYA
CCCCCCCCCCCCCCE
18.0128152594
493PhosphorylationYEDPYYGYDDGYAVR
CCCCCCCCCCCCEEC
8.5028152594
497PhosphorylationYYGYDDGYAVRGRGG
CCCCCCCCEECCCCC
14.6628152594
500MethylationYDDGYAVRGRGGGRG
CCCCCEECCCCCCCC
22.4024383367
502MethylationDGYAVRGRGGGRGGR
CCCEECCCCCCCCCC
29.9824395437
506MethylationVRGRGGGRGGRGAPP
ECCCCCCCCCCCCCC
47.90115479389
509MethylationRGGGRGGRGAPPPPR
CCCCCCCCCCCCCCC
40.71115479395
529PhosphorylationPPRGRAGYSQRGAPL
CCCCCCCCCCCCCCC
10.7228152594
530PhosphorylationPRGRAGYSQRGAPLG
CCCCCCCCCCCCCCC
16.6928152594
532MethylationGRAGYSQRGAPLGPP
CCCCCCCCCCCCCCC
36.9824383375
542PhosphorylationPLGPPRGSRGGRGGP
CCCCCCCCCCCCCCH
29.0922468782
573MethylationGGNVGGKRKADGYNQ
CCCCCCCCCCCCCCC
42.54-
574UbiquitinationGNVGGKRKADGYNQP
CCCCCCCCCCCCCCC
55.08-
578PhosphorylationGKRKADGYNQPDSKR
CCCCCCCCCCCCHHH
15.9228102081
583PhosphorylationDGYNQPDSKRRQTNN
CCCCCCCHHHCCCCC
34.4421815630
584AcetylationGYNQPDSKRRQTNNQ
CCCCCCHHHCCCCCC
60.0125953088
584UbiquitinationGYNQPDSKRRQTNNQ
CCCCCCHHHCCCCCC
60.01-
586 (in isoform 2)Phosphorylation-51.9527251275
588PhosphorylationPDSKRRQTNNQQNWG
CCHHHCCCCCCCCCC
34.0326074081
596PhosphorylationNNQQNWGSQPIAQQP
CCCCCCCCCCCCCCC
25.1326074081
610PhosphorylationPLQQGGDYSGNYGYN
CHHCCCCCCCCCCCC
23.0428348404
611PhosphorylationLQQGGDYSGNYGYNN
HHCCCCCCCCCCCCC
25.8828348404
614PhosphorylationGGDYSGNYGYNNDNQ
CCCCCCCCCCCCCCH
25.2228348404
616PhosphorylationDYSGNYGYNNDNQEF
CCCCCCCCCCCCHHH
10.6328348404
624PhosphorylationNNDNQEFYQDTYGQQ
CCCCHHHHHHCCCCC
12.5328348404
627PhosphorylationNQEFYQDTYGQQWK-
CHHHHHHCCCCCCC-
17.64-
628PhosphorylationQEFYQDTYGQQWK--
HHHHHHCCCCCCC--
22.64-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of HNRPR_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of HNRPR_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HNRPR_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RL26_HUMANRPL26physical
16169070
ANM1_HUMANPRMT1physical
16169070
SMN_HUMANSMN1physical
11574476
ROA1_HUMANHNRNPA1physical
22939629
SRSF1_HUMANSRSF1physical
22939629
U520_HUMANSNRNP200physical
22939629
U5S1_HUMANEFTUD2physical
22939629
SF3B3_HUMANSF3B3physical
22939629
SF3B1_HUMANSF3B1physical
22939629
SF3A1_HUMANSF3A1physical
22939629
SF3A3_HUMANSF3A3physical
22939629
SRSF5_HUMANSRSF5physical
22939629
SFPQ_HUMANSFPQphysical
22939629
U2AF2_HUMANU2AF2physical
22939629
RU17_HUMANSNRNP70physical
22939629
PABP1_HUMANPABPC1physical
22939629
NPM_HUMANNPM1physical
22939629
TADBP_HUMANTARDBPphysical
22939629
ROA0_HUMANHNRNPA0physical
22939629
SNUT1_HUMANSART1physical
22939629
RALY_HUMANRALYphysical
22939629
IF4A3_HUMANEIF4A3physical
22939629
ILF3_HUMANILF3physical
22939629
ILF2_HUMANILF2physical
22939629
PR40A_HUMANPRPF40Aphysical
22939629
KHDR1_HUMANKHDRBS1physical
22939629
RM42_HUMANMRPL42physical
22939629
TOP2B_HUMANTOP2Bphysical
22939629
VTNC_HUMANVTNphysical
22939629
MYO1C_HUMANMYO1Cphysical
22939629
RM04_HUMANMRPL4physical
22939629
RM14_HUMANMRPL14physical
22939629
MPV17_HUMANMPV17physical
22939629
TF3C1_HUMANGTF3C1physical
22939629
LMO7_HUMANLMO7physical
22939629
RM23_HUMANMRPL23physical
22939629
RS23_HUMANRPS23physical
22939629
RAD50_HUMANRAD50physical
22939629
NDUV1_HUMANNDUFV1physical
22939629
MTX2_HUMANMTX2physical
22939629
TIM10_HUMANTIMM10physical
22939629
TOM22_HUMANTOMM22physical
22939629
PRR3_HUMANPRR3physical
22939629
NPL4_HUMANNPLOC4physical
22939629
SPTN1_HUMANSPTAN1physical
22939629
SPG7_HUMANSPG7physical
22939629
LBR_HUMANLBRphysical
22939629
RT09_HUMANMRPS9physical
22939629
MIRO2_HUMANRHOT2physical
22939629
SND1_HUMANSND1physical
22939629
SMCA5_HUMANSMARCA5physical
22939629
K2013_HUMANKIAA2013physical
22939629
RBM14_HUMANRBM14physical
22939629
SLIRP_HUMANSLIRPphysical
22939629
RL31_HUMANRPL31physical
22939629
PTSS2_HUMANPTDSS2physical
22939629
MIC60_HUMANIMMTphysical
22939629
RT28_HUMANMRPS28physical
22939629
RT16_HUMANMRPS16physical
22939629
LGMN_HUMANLGMNphysical
22939629
RM40_HUMANMRPL40physical
22939629
PEX3_HUMANPEX3physical
22939629
NICA_HUMANNCSTNphysical
22939629
MBB1A_HUMANMYBBP1Aphysical
22939629
RT21_HUMANMRPS21physical
22939629
MOGS_HUMANMOGSphysical
22939629
T179B_HUMANTMEM179Bphysical
22939629
K1C18_HUMANKRT18physical
22939629
RT26_HUMANMRPS26physical
22939629
IL7RA_HUMANIL7Rphysical
23151878
BRCC3_HUMANBRCC3physical
22863883
CD2AP_HUMANCD2APphysical
22863883
EH1L1_HUMANEHBP1L1physical
22863883
GAPD1_HUMANGAPVD1physical
22863883
LARP7_HUMANLARP7physical
22863883
MAP4_HUMANMAP4physical
22863883
MTA2_HUMANMTA2physical
22863883
RPB1_HUMANPOLR2Aphysical
22863883
PP4R1_HUMANPPP4R1physical
22863883
RABE2_HUMANRABEP2physical
22863883
WDHD1_HUMANWDHD1physical
22863883
KHDR2_HUMANKHDRBS2physical
25416956
DDX3X_HUMANDDX3Xphysical
26344197
DDX5_HUMANDDX5physical
26344197
MO4L1_HUMANMORF4L1physical
26344197
MO4L2_HUMANMORF4L2physical
26344197
NAA15_HUMANNAA15physical
26344197
NH2L1_HUMANNHP2L1physical
26344197
PRP8_HUMANPRPF8physical
26344197
RL7_HUMANRPL7physical
26344197
PAIRB_HUMANSERBP1physical
26344197
SF3B3_HUMANSF3B3physical
26344197
TRM6_HUMANTRMT6physical
26344197
ZFR_HUMANZFRphysical
28514442
RU17_HUMANSNRNP70physical
28514442
RT05_HUMANMRPS5physical
28514442
RT31_HUMANMRPS31physical
28514442

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HNRPR_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-103; LYS-366; LYS-389 ANDLYS-397, AND MASS SPECTROMETRY.

TOP